Groowe Groowe / Newsroom / ZURA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ZURA News

Zura Bio Limited Class A Ordinary Shares

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

businesswire.com
ZURA

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

businesswire.com
ZURA

Form 8-K

sec.gov
ZURA

Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit

businesswire.com
ZURA

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer

businesswire.com
ZURA

Zura Bio Reports Business Updates and Outlook for 2026

businesswire.com
ZURA

CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer

businesswire.com
RPRX ABBV NVS ZURA INCY AZN

Zura Bio Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zura Bio Limited (ZURA)

prnewswire.com
ZURA

ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited

prnewswire.com
ZURA